Evidence map›Paper›PMID 34041346›Full record

ArticleOne health (Amsterdam, Netherlands)2021

Prioritization of zoonotic diseases of public health significance in Nigeria using the one-health approach.

Chikwe Ihekweazu, Charles Akataobi Michael, Patrick M Nguku, Ndadilnasiya Endie Waziri, Abdulrazaq Garba Habib, Mathew Muturi, Abayomi Olufemi, Asabe A Dzikwi-Emennaa, Muhammad Shakir Balogun, Tyakaray Ibrahim Visa and 13 more

Abstract read
In one paragraph

Article in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Design and Implementation of a One Health Framework for Evaluating the Transmission Potential of Pathogens of Public Health Interest for Surveillance Studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Animal Disease Burden in Nigeria, 2006-2023.Transboundary and emerging diseases · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Chikwe IhekweazuNigeria Centre for Disease Control, Abuja, Nigeria.
Charles Akataobi MichaelAfrica Field Epidemiology Network, Asokoro, Abuja, Nigeria.
Patrick M NgukuAfrica Field Epidemiology Network, Asokoro, Abuja, Nigeria.
Ndadilnasiya Endie WaziriAfrica Field Epidemiology Network, Asokoro, Abuja, Nigeria.
Abdulrazaq Garba HabibBayero University, Kano, Nigeria.
Mathew MuturiKenya Zoonotic Disease Unit, Directorate of Veterinary Services, Kenya.
Abayomi OlufemiNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Asabe A Dzikwi-EmennaaUniversity of Jos, Plateau State, Nigeria.
Muhammad Shakir BalogunAfrica Field Epidemiology Network, Asokoro, Abuja, Nigeria.
Tyakaray Ibrahim VisaNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Mahmood Muazu DalhatAfrica Field Epidemiology Network, Asokoro, Abuja, Nigeria.
Nnomzie Charles AtamaNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Chukwuma David UmeokonkwoNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Gideon Mbrusa MshelbwalaFederal Ministry of Agriculture and Rural Development, Abuja, Nigeria.
Columba Teru VakuruFederal Ministry of Agriculture and Rural Development, Abuja, Nigeria.
Junaidu KabirAhmadu Bello University, Zaria, Kaduna State, Nigeria.
Emmanuel C OkolochaAhmadu Bello University, Zaria, Kaduna State, Nigeria.
Jarlath U UmohAkwa Ibom State University, Akwa Ibom State, Nigeria.
Babasola OlugasaUniversity of Ibadan, Oyo State, Nigeria.
Olutayo BabalobiUniversity of Ibadan, Oyo State, Nigeria.
Lami LombinUniversity of Jos, Plateau State, Nigeria.
Simeon CadmusUniversity of Ibadan, Oyo State, Nigeria.
Nigeria Zoonotic Diseases Prioritization Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nigeria, with a population of over 190 million people, is rated among the 10 countries with the highest burden of infectious and zoonotic diseases globally. In Nigeria, there exist a sub-optimal surveillance system to monitor and track priority zoonoses. We therefore conducted a prioritization of zoonotic diseases for the first time in Nigeria to guide prevention and control efforts. Towards this, a two-day in-country consultative meeting involving experts from the human, animal, and environmental health backgrounds prioritized zoonotic diseases using a modified semi-quantitative One Health Zoonotic Disease Prioritization tool in July 2017. Overall, 36 of 52 previously selected zoonoses were identified for prioritization. Five selection criteria were used to arrive at the relative importance of prioritized diseases based on their weighted score. Overall, this zoonotic disease prioritization process marks the first major step of bringing together experts from the human-animal-environment health spectrum in Nigeria. Importantly, the country ranked rabies, avian influenza, Ebola Virus Disease, swine influenza and anthrax as the first five priority zoonoses in Nigeria. Finally, this One Health approach to prioritizing important zoonoses is a step that will help to guide future tracking and monitoring of diseases of grave public health importance in Nigeria.

Indexed as

NigeriaOne HealthPrioritizationPublic HealthZoonotic diseases

Identifiers

PMID34041346
PMCPMC8144726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.